XBiotech XBIT
NASDAQ XBIT
$2.28 -0.03 (-1.30%)
As of: Aug 21, 2026 · 3:59 PM EDT

XBiotech (XBIT) Interest & Investment Income (2017 - 2026)

XBiotech (XBIT) posted quarterly Interest & Investment Income of $1.2 million for Q4 2025, down 41.84% year-over-year from $2.1 million in Q4 2024, and down 14.58% quarter-over-quarter from $1.4 million in Q3 2025.

XBiotech (XBIT) Interest & Investment Income (2017 - 2026) Analysis & Trends

XBiotech's Interest & Investment Income history runs 9 years deep, the most recent figure standing at $1.2 million for Q4 2025.

  • In Q4 2025, Interest & Investment Income fell 41.84% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $5.7 million (down 42.11% YoY), while the FY2025 annual figure was $5.7 million, down 42.12% from the prior year.
  • Interest & Investment Income for Q4 2025 stood at $1.2 million, down from $1.4 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $2.8 million in Q1 2023, with the low at $101000.0 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $1.5 million (2025), against an average of $1.5 million.
  • The sharpest annual moves came in 2021 and 2023: Interest & Investment Income slumped 94.26% in 2021, then surged 2651.49% in 2023.
  • XBiotech's Interest & Investment Income stood at $110000.0 in 2021, then soared by 2147.27% to $2.5 million in 2022, then gained by 5.3% to $2.6 million in 2023, then fell by 19.48% to $2.1 million in 2024, then slumped by 41.84% to $1.2 million in 2025.
  • Business Quant data shows XBIT's Interest & Investment Income at $1.2 million in Q4 2025, $1.4 million in Q3 2025, and $1.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 XBiotech 69.51 Mn 69.51 Mn - 885,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 885,000.00
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.43 Mn
Jun 30, 2025 1.53 Mn
Mar 31, 2025 1.50 Mn
Dec 31, 2024 2.10 Mn
Sep 30, 2024 2.37 Mn
Jun 30, 2024 2.69 Mn
Mar 31, 2024 2.66 Mn
Dec 31, 2023 2.60 Mn
Sep 30, 2023 2.53 Mn
Jun 30, 2023 2.51 Mn
Mar 31, 2023 2.78 Mn
Dec 31, 2022 2.47 Mn
Sep 30, 2022 1.01 Mn
Jun 30, 2022 241,000.00
Mar 31, 2022 101,000.00
Dec 31, 2021 110,000.00
Sep 30, 2021 125,000.00
Jun 30, 2021 123,000.00